Addressing the future needs for the biotech sector
Hong Kong Life Sciences Society (HKLSS) was established in 2018, with the aim to develop an intricate, world-class industry cluster in Hong Kong by connecting with different stakeholders, regional and global partners in life sciences and biotechnology sectors.
Fully backed by biotech companies and Nan Fung Life Sciences (Nan Fung Group)
HKLSS is fully backed by the Nan Fung Group and supported by biotech companies in Hong Kong and Mainland China. Our partners cover venture capitals, multi-national corporations, pharmaceutical companies and biotech start-ups including Antengene Corporation, Arctic Vision, AstraZeneca, Morningside, Shanghai Omni Pharmaceutical, Oncologie, Pivotal bioVenture Partners China, Sumitomo Pharmaceuticals, WuXi AppTec and WuXi Biologics. Apart from partnering with renowned biotech companies, HKLSS works closely with Nan Fung Life Sciences, ensuring that young talents are able to learn from and be guided by industry professionals and senior executives from life science and biotechnology sectors.